<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long‐term central venous catheters in infants and children - Bradford, NK - 2020 | Cochrane Library</title> <meta content="Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long‐term central venous catheters in infants and children - Bradford, NK - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010996.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long‐term central venous catheters in infants and children - Bradford, NK - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010996.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010996.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long‐term central venous catheters in infants and children" name="citation_title"/> <meta content="Natalie K Bradford" name="citation_author"/> <meta content="Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT)" name="citation_author_institution"/> <meta content="natalie.bradford@qut.edu.au" name="citation_author_email"/> <meta content="Rachel M Edwards" name="citation_author"/> <meta content="Queensland Children's Hospital" name="citation_author_institution"/> <meta content="Raymond J Chan" name="citation_author"/> <meta content="Queensland University of Technology" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD010996.pub3" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/04/30" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010996.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010996.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010996.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Catheter Obstruction [statistics &amp; numerical data]; Catheter-Related Infections [epidemiology, prevention &amp; control]; *Central Venous Catheters [adverse effects, statistics &amp; numerical data]; Fibrinolytic Agents [*administration &amp; dosage]; Heparin [*administration &amp; dosage]; Randomized Controlled Trials as Topic; Sodium Chloride [*administration &amp; dosage]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010996.pub3&amp;doi=10.1002/14651858.CD010996.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="jiwTpTuf";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010996\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010996\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010996\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010996\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","fa","fr","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010996.pub3",title:"Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long\\u2010term central venous catheters in infants and children",firstPublishedDate:"Apr 30, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Vascular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jiwTpTuf&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010996.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010996.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010996.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010996.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010996.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010996.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010996.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010996.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010996.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010996.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>15255 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010996.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/full#CD010996-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/full#CD010996-sec-0076"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/full#CD010996-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/full#CD010996-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/full#CD010996-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/full#CD010996-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/full#CD010996-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/full#CD010996-sec-0067"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/appendices#CD010996-sec-0081"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/table_n/CD010996StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/table_n/CD010996StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long‐term central venous catheters in infants and children </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/information#CD010996-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Natalie K Bradford</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/information#CD010996-cr-0005">Rachel M Edwards</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010996.pub3/information#CD010996-cr-0006">Raymond J Chan</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/information/en#CD010996-sec-0086">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 30 April 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010996.pub3">https://doi.org/10.1002/14651858.CD010996.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010996-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010996-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010996-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010996-abs-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010996-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010996-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010996-abs-0001" lang="en"> <section id="CD010996-sec-0001"> <h3 class="title" id="CD010996-sec-0001">Background</h3> <p>Guidelines and clinical practice for the prevention of complications associated with central venous catheters (CVC) around the world vary greatly. Most institutions recommend the use of heparin to prevent occlusion; there is debate, however, regarding the need for heparin and evidence to suggest normal saline (0.9% sodium chloride) may be as effective. The use of heparin is not without risk, may be unnecessary and is also associated with increased cost. This is an update of the review published in 2015. </p> </section> <section id="CD010996-sec-0002"> <h3 class="title" id="CD010996-sec-0002">Objectives</h3> <p>To assess the clinical effects (benefits and harms) of intermittent flushing of normal saline versus heparin to prevent occlusion in long‐term central venous catheters in infants and children. </p> </section> <section id="CD010996-sec-0003"> <h3 class="title" id="CD010996-sec-0003">Search methods</h3> <p>The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, CENTRAL, MEDLINE, Embase and CINAHL databases; World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials register to 9 April 2019. We also undertook reference checking, citation searching and contact with study authors to identify additional studies. </p> </section> <section id="CD010996-sec-0004"> <h3 class="title" id="CD010996-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) that compared the efficacy of intermittent flushing with normal saline versus heparin to prevent occlusion of long‐term CVCs in infants and children aged up to 18 years of age. We excluded temporary CVCs and peripherally inserted central catheters (PICC). </p> </section> <section id="CD010996-sec-0005"> <h3 class="title" id="CD010996-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed trial inclusion criteria, trial quality and extracted data. We assessed study quality with the Cochrane 'Risk of bias' tool. For dichotomous outcomes, we calculated the rate ratio (RR) and corresponding 95% confidence interval (CI). We pooled data using a random‐effects model; and we used GRADE to assess the overall certainty of the evidence supporting the outcomes assessed in this review. </p> </section> <section id="CD010996-sec-0006"> <h3 class="title" id="CD010996-sec-0006">Main results</h3> <p>We identified one new study for this update, bringing the total number of included studies to four (255 participants). The four trials directly compared the use of normal saline and heparin; the studies all used different protocols for the intervention and control arms, however, and all used different concentrations of heparin. Different frequencies of flushes were also reported between studies. In addition, not all studies reported on all outcomes. The certainty of the evidence ranged from moderate to very low because there was no blinding; heterogeneity and inconsistency between studies was high; and the CIs were wide. CVC occlusion was assessed in all four trials. We were able to pool the results of two trials for the outcomes of CVC occlusion and CVC‐associated blood stream infection. The estimated RR for CVC occlusion per 1000 catheter days between the normal saline and heparin groups was 0.75 (95% CI 0.10 to 5.51; 2 studies, 229 participants; very low certainty evidence). The estimated RR for CVC‐associated blood stream infection was 1.48 (95% CI 0.24 to 9.37; 2 studies, 231 participants; low‐certainty evidence). The duration of catheter placement was reported to be similar for the two study arms in one study (203 participants; moderate‐certainty evidence), and not reported in the remaining studies. </p> </section> <section id="CD010996-sec-0007"> <h3 class="title" id="CD010996-sec-0007">Authors' conclusions</h3> <p>The review found that there was not enough evidence to determine the effects of intermittent flushing with normal saline versus heparin to prevent occlusion in long‐term central venous catheters in infants and children. It remains unclear whether heparin is necessary to prevent occlusion, CVC‐associated blood stream infection or effects duration of catheter placement. Lack of agreement between institutions around the world regarding the appropriate care and maintenance of these devices remains. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010996-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010996-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010996-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010996-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010996-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010996-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010996-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD010996-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010996-abs-0002" lang="en"> <h3>Replacing heparin flushing with saline flushing to prevent complications in long‐term central venous catheters in children </h3> <p><b>Background</b> </p> <p>A central venous catheter (CVC) is a long, thin, flexible tube which is inserted into a large central vein. This enables access to the blood stream for people with serious medical conditions to receive medications and fluids, as well as the collection of blood specimens. Long‐term CVCs are used to access the blood system in children with complex medical conditions like cancer. To stop the catheter from becoming blocked it is usual to use heparin, a drug that prevents clots forming, to flush the catheter. However, some studies have shown that heparin is not necessary, and that normal saline (a sterile salt water solution) can be safely used instead. Heparin may be associated with complications, such as bleeding and infection, along with higher costs for healthcare providers. While the complications such as infections and occlusions are uncommon, practices vary around the world and there are many inconsistencies regarding the best flush solution to use to prevent complications in long‐term catheters. </p> <p><b>Study characteristics and key results</b> </p> <p>This review included randomised controlled trials (clinical studies where people were randomly assigned into one of two or more treatment groups) that compared the use of saline and heparin to prevent blockage, and other complications related to long‐term catheters. The evidence is current to 9 April 2019. Two review authors independently reviewed the studies. We included four studies with a total of 255 participants in the review. The four trials were all undertaken in large teaching (tertiary) hospitals, and directly compared the use of saline and heparin. The studies were, however, very different in the way they compared saline and heparin, with different concentrations of heparin and different frequencies of flushes reported. We were able to combine the results of two studies: the analysis showed imprecise results for the blocking of catheters and blood stream infections for normal saline versus heparin. One study reported the duration of catheter placement to be similar between the two study arms. </p> <p><b>Certainty of the evidence</b> </p> <p>The overall certainty of the evidence ranged from moderate to very low. There was high risk of bias for blinding, there were differences between the studies methods and interventions, inconsistent results between the studies, and not all studies reported all outcomes of interest. We found there was not enough evidence to determine which solution, saline or heparin, is more effective for reducing complications. Further research is required and is likely to have an important impact in this area. This review is an update of a review first published in 2015. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010996-sec-0076" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010996-sec-0076"></div> <h3 class="title" id="CD010996-sec-0077">Implications for practice</h3> <section id="CD010996-sec-0077"> <p>There is insufficient evidence to determine the effects of intermittent flushing with normal saline versus heparin to prevent occlusion in long‐term central venous catheters in infants and children. It remains unclear whether heparin is necessary to prevent occlusion, CVC‐associated blood stream infection or the effects of prolonged catheter placement. Lack of agreement remains between institutions around the world regarding the appropriate care and maintenance of these devices. </p> </section> <h3 class="title" id="CD010996-sec-0078">Implications for research</h3> <section id="CD010996-sec-0078"> <p>Given the results of this review, there is a need for healthcare organisations to consider undertaking further research in this area to contribute to the evidence base. Ultimately this would facilitate the development of evidence‐based clinical practice guidelines and consistency of practice. Careful attention to study design is required, including blinding and proper sample size calculations to detect clinically meaningful differences, and ensuring only one aspect of the intervention is changed in the intervention arm (flushing frequency, concentration of heparin or use of normal saline). Additionally, reporting on variables that may influence outcomes, such as catheter maintenance processes, infection control processes and packaging of  flush solutions, would assist with evaluation. Such studies would generate evidence and ensure results could be appraised and generalised to address the current gaps in knowledge. Consistency of outcome reporting would aid interpretation of results. No studies measured the costs associated with the intervention or control arms. If efficacy is similar between both normal saline and heparin, then the use of heparin incurs costs to health systems with no advantages; cost analysis would be a useful addition to future studies. Alternatively, decision models could be used to ascertain what differences in complication rates would make a meaningful difference in costs or outcomes. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010996-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010996-sec-0008"></div> <div class="table" id="CD010996-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Does normal saline flushing in long‐term central venous catheters (CVC) prevent occlusion compared to heparin flushing in infants and children?</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Normal saline versus heparin flushing for prevention of occlusion in long‐term CVC in infants and children</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> infants and children with a long‐term CVC<br/><b>Settings:</b> tertiary hospitals<br/><b>Intervention:</b> normal saline flush<br/><b>Control:</b> heparin flush </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects * (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(RCTs)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p>Risk with <b>heparin flush</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p>Risk with <b>normal saline flush</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>CVC occlusion rate per 1000 catheter days:</b> ability to infuse solution through CVC </p> <p>Follow‐up: 3029 to 115,991 at‐risk days</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Rate ratio 0.75</b> <br/>(0.10 to 5.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>229<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>551 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>507 per 1000</b><br/>(99 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>CVC‐associated blood stream infection rate per 1000 catheter days:</b> incidence of positive blood culture </p> <p>Follow‐up: 3029 to 115,991 at‐risk days</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Rate ratio 1.48</b> <br/>(0.24 to 9.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>231<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>93 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>209 per 1000</b><br/>(103 to 425) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Duration of CVC placement (days)</b> </p> <p>Follow up: median 360 days</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>203</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b><sup>1,4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> reported this in terms of survival, not in days. Mean survival was reported as 77% (95% CI 66% to 84%) in the normal saline group and 69% (95% CI 53% to 80%) in the heparin group. No differences were found in cause or frequency of premature removal of catheter between study arms. The remaining studies did not report on this outcome. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>CVC</b> : Central venous catheter; <b>RCTs</b>: Randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>No blinding in either study. Performance and detection bias is high in both studies<br/><sup>2</sup>Heterogeneity and inconsistency between studies is high<br/><sup>3</sup>Confidence intervals were wide and included the null hypothesis<br/><sup>4</sup>Results could be attributed to other factors associated with the use of heparin<br/><sup>5</sup>The outcomes could also be attributed to the use of positive pressure cap in the <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> study  </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010996-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010996-sec-0009"></div> <section id="CD010996-sec-0010"> <h3 class="title" id="CD010996-sec-0010">Description of the condition</h3> <p>A central venous catheter (CVC) is a long, thin, flexible tube which is inserted into a large central vein, with the tip of the catheter ideally placed within the superior vena cava (<a href="./references#CD010996-bbs2-0056" title="SchusterM , NaveH , PiepenbrockS , PabstR , PanningB . The carina as a landmark in central venous catheter placement. British Journal of Anaesthesia2000;85(2):192-4.">Schuster 2000</a>). This enables the administration of medications and fluids, as well as the collection of blood specimens, and avoids multiple venipunctures. CVCs are commonly known as 'central lines' or by their brand name including Broviac, Hickman, and Port‐a‐Cath. The use of long‐term CVCs for the management of chronic medical conditions in infants and children has greatly improved the quality and safety of care provision. Long‐term CVCs are typically inserted when the administration of intravenous medication or nutritional support is required over a considerable time period. Hypertonic medications such as vesicant chemotherapy drugs, certain antibiotics, other supportive drugs and parenteral nutrition cannot be safely administered through peripheral venous catheters. For children with cancer and other chronic medical conditions who require such medications, this safety issue is overcome by the insertion of a CVC which commonly remains in place for the duration of treatment (<a href="./references#CD010996-bbs2-0037" title="GonzalezG , DavidoffAM , HowardSC , PuiCH , RaoBN , ShenepJL , et al. Safety of central venous catheter placement at diagnosis of acute lymphoblastic leukemia in children. Pediatric Blood &amp; Cancer2012;58(4):498-502.">Gonzalez 2012</a>). There are three types of long‐term CVCs: tunnelled catheters; totally implanted catheters; and peripherally inserted central catheters (PICC). A tunnelled CVC is surgically inserted under the skin, with the catheter lumen(s) typically exiting from the chest or neck. A totally implanted catheter is also surgically inserted, but is placed entirely under the skin and commonly referred to as a 'port'. The port reservoir is accessed with a needle through the skin. A PICC line is inserted into a central vein through the arm and thus is a narrower catheter. </p> <p>Adverse events associated with CVCs may cause complications in up to 46% of children (<a href="./references#CD010996-bbs2-0024" title="AthaleUH , SicilianoS , ChengJ , ThabaneL , ChanAK . Central venous line dysfunction is an independent predictor of poor survival in children with cancer. Journal of Pediatric Hematology/oncology2012;34(3):188-93.">Athale 2012</a>). Adverse events in the scope of this review include mechanical failure, catheter fracture, infections and intravascular thrombosis, all of which can affect patient morbidity and mortality (<a href="./references#CD010996-bbs2-0027" title="BaskinJL , Pui C-H, ReissU , WilimasJA , MetzgerML , RibeiroRC , et al. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet2009;374(9684):159-69.">Baskin 2009</a>; <a href="./references#CD010996-bbs2-0036" title="FratinoG , MolinariAC , ParodiS , LongoS , SaraccoP , CastagnolaE , et al. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Annals of Oncology2005;16(4):648-54.">Fratino 2005</a>; <a href="./references#CD010996-bbs2-0061" title="StoccoJGD , CrozetaK , TaminatoM , Reichembach-DanskiMT , MeierMJ . Evaluation of the mortality of neonates and children related to the use of central venous catheters: a systematic review. Acta Paulista de Enfermagem2012;25(1):90-5.">Stocco 2012</a>; <a href="./references#CD010996-bbs2-0062" title="WongT , CliffordV , McCallumZ , ShalleyH , PeterkinM , PaxtonG , et al. Central venous catheter thrombosis associated with 70% ethanol locks in pediatric intestinal failure patients on home parenteral nutrition. A case series. Journal of Parenteral and Enteral Nutrition2012;36(3):358-60.">Wong 2012</a>). Mechanical failure is often attributed to catheter occlusion. Over time, it is common for a fibrin sheath to develop at the tip of the catheter. The fibrin sheath may prevent aspiration of blood from the catheter and cause resistance when infusing fluids. An intraluminal clot can also occur, which can totally occlude the catheter. Intraluminal clots may occur as a result of precipitate from medications, which would not be prevented by use of heparin; or from blood refluxing into the catheter lumen and forming a clot. Occlusion can result in the need for the catheter to be removed (and replaced), interrupting and delaying treatment of the underlying disease (<a href="./references#CD010996-bbs2-0058" title="ShahPS , KalynA , SatodiaP , DunnMS , ParvezB , DanemanA , et al. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study. Pediatrics2007;119(1):e284-e91.">Shah 2007</a>). Occlusions of CVCs are estimated to occur in 14% to 36% of patients within one to two years of catheter insertion (<a href="./references#CD010996-bbs2-0036" title="FratinoG , MolinariAC , ParodiS , LongoS , SaraccoP , CastagnolaE , et al. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Annals of Oncology2005;16(4):648-54.">Fratino 2005</a>); or at an incidence rate of 1.35 per 1000 catheter days (95% confidence interval (CI) 1.10 to 1.63) (<a href="./references#CD010996-bbs2-0053" title="Revel-VilkS , YacobovichJ , TamaryH , GoldsteinG , NemetS , WeintraubM , et al. Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer. Cancer2010;116(17):4197-205.">Revel‐Vilk 2010</a>). Incidence rates of central‐line‐associated blood stream infection differ depending upon the type of catheter, with rates reported between 1.40 per 1000 catheter days (95% CI 1.06 to 1.82) and 0.46 per 1000 catheter days (95% CI 0.29 to 0.69). Intravascular thrombosis is the rarest adverse event reported in children, with a lower incidence rate of 0.08 per 1000 catheter days (95% CI 0.04 to 0.16), and can only be diagnosed by radiographic methods (<a href="./references#CD010996-bbs2-0036" title="FratinoG , MolinariAC , ParodiS , LongoS , SaraccoP , CastagnolaE , et al. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Annals of Oncology2005;16(4):648-54.">Fratino 2005</a>). Intravascular thrombosis may or may not occur concurrently with other complications. </p> </section> <section id="CD010996-sec-0011"> <h3 class="title" id="CD010996-sec-0011">Description of the intervention</h3> <p>A flush refers to a solution of 0.9% sodium chloride (normal saline) injected to clear or 'rinse' the catheter of blood or fibrin build‐up. This is commonly used when the catheter is accessed, between administration of medications, or before and after collection of blood specimens. A lock is used to instil fluid into the catheter when the catheter will not be accessed for a period of time. A positive pressure lock refers to the technique used to ensure blood does not flow back into the catheter after it is flushed, which may otherwise clot and cause occlusion. Tunnelled CVCs and PICC lines are typically flushed and locked weekly, while implanted ports are flushed and locked every 4 to 6 weeks. A typical lock solution for tunnelled catheters in children is to use between 1 mL to 3 mL (depending on the volume of the catheter) of 10 units/mL of heparin for a 24‐hour to 7‐day lock. For implanted ports, 5 mL of 100 units/mL is typically used as a lock solution for a 30‐day lock (<a href="./references#CD010996-bbs2-0033" title="DavisMB . Pediatric central venous catheter management: a review of current practice. Journal of the Association for Vascular Access2013;18(2):93-8.">Davis 2013</a>). There is debate, however, regarding the effectiveness of heparin to prevent occlusion over such time periods, given its short half‐life (<a href="./references#CD010996-bbs2-0063" title="YoungG . New anticoagulants in children. ASH Education Program Book2008;1:245-50.">Young 2008</a>). The evidence to support the use of heparin to prevent occlusion in adult CVCs is inconclusive and there is growing evidence to support the use of normal saline to lock CVCs, particularly in the paediatric population (<a href="./references#CD010996-bbs2-0028" title="BertoglioS , SolariN , MeszarosP , VassalloF , BonventoM , PastorinoS , et al. Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients. Cancer Nursing2012;35(4):E35-42.">Bertoglio 2012</a>; <a href="./references#CD010996-bbs2-0046" title="LeeOK , JohnstonL . A systematic review for effective management of central venous catheters and catheter sites in acute care paediatric patients. Worldviews on Evidence-based Nursing / Sigma Theta Tau International, Honor Society of Nursing2005;2(1):4-13, discussion 14-5.">Lee 2005</a>). In paediatrics, there is an additional risk of bleeding due to overdose of heparin from frequent flushing or incorrect dilution. </p> </section> <section id="CD010996-sec-0012"> <h3 class="title" id="CD010996-sec-0012">How the intervention might work</h3> <p>Heparin is used to prevent occlusion because of its anticoagulant properties which are believed to prevent thrombus forming in the catheter. Alternatively normal saline, when used with pulsatile (push‒pause rather than continuous) flushing techniques and a positive pressure lock or positive displacement device, may be as effective in preventing thrombus formation in catheters—eliminating the need for heparin to be used (<a href="./references#CD010996-bbs2-0028" title="BertoglioS , SolariN , MeszarosP , VassalloF , BonventoM , PastorinoS , et al. Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients. Cancer Nursing2012;35(4):E35-42.">Bertoglio 2012</a>). </p> </section> <section id="CD010996-sec-0013"> <h3 class="title" id="CD010996-sec-0013">Why it is important to do this review</h3> <p>Catheter maintenance practices vary among institutions because of the lack of evidence regarding best practice to prevent occlusion of CVCs. Variations include the quantity of flush and lock solutions, the proportional volume of heparin lock solution, the concentration of heparin, and the frequency of flushes and locks. The use of heparin is not risk free and in certain instances may actually cause harm, including infection (<a href="./references#CD010996-bbs2-0059" title="ShanksRM , DoneganNP , GraberML , BuckinghamSE , ZegansME , CheungAL , et al. Heparin stimulates Staphylococcus aureus biofilm formation. Infection and Immunity2005;73(8):4596-606.">Shanks 2005</a>), and heparin‐induced thrombocytopenia (HIT) (<a href="./references#CD010996-bbs2-0026" title="BarclayCA , VonderhaarKJ , ClarkEA . The development of evidence-based care recommendations to improve the safe use of anticoagulants in children. Journal of Pediatric Pharmacology and Therapeutics2012;17(2):155-8.">Barclay 2012</a>). The mechanism of haemostasis in children is different when compared to adults, particularly in infants and very young children; and the evidence suggests algorithms used in adults are unlikely to be valid in children (<a href="./references#CD010996-bbs2-0051" title="MonagleP , IgnjatovicV , SavoiaH . Hemostasis in neonates and children: pitfalls and dilemmas. Blood Reviews2010;24(2):63-8.">Monagle 2010</a>). Additionally, treatments for diseases such as cancer involve the use of medications which can affect coagulation. In the absence of specific data related to paediatrics, using evidence based on adults may be inappropriate and there is a need for paediatric‐specific studies (<a href="./references#CD010996-bbs2-0051" title="MonagleP , IgnjatovicV , SavoiaH . Hemostasis in neonates and children: pitfalls and dilemmas. Blood Reviews2010;24(2):63-8.">Monagle 2010</a>). For these reasons the use of heparin to prevent CVC occlusion should be judicious and evidence based. While the risks of adverse effects from the use of heparin may be regarded as less than those which might arise from occlusion of a catheter and subsequent replacement, it is important to ensure interventions are based on evidence. </p> <p>In the adult population, there have been several trials investigating heparin versus normal saline to prevent occlusions in CVCs, six of which are summarised in a Cochrane Review (<a href="./references#CD010996-bbs2-0048" title="Lopez-BrizE , Ruiz GarciaV , CabelleJB , Bort-MartiS , Carbonell SanchisR , BurlsA . Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults. Cochrane Database of Systematic Reviews2018, Issue 7. [DOI: 10.1002/14651858.CD008462.pub3]">Lopez‐Briz 2018</a>). As evidence from adult studies is not directly transferable to paediatrics, systematic reviews focused on infants and children are required. A review published in 2014 that did relate specifically to paediatrics did not identify all relevant studies and made recommendations based on the current practice of several institutions (<a href="./references#CD010996-bbs2-0030" title="ConwayMA , McCollomC , BannonC . Central venous catheter flushing recommendations: a systematic evidenced-based practice review. Journal of Pediatric Oncology Nursing2014;31(4):185-90.">Conway 2014</a>). These recommendations were not evidence based, and are contrary to the practice of many other institutions. It is important, therefore, to systematically appraise the evidence for the use of normal saline compared with heparin to prevent occlusion of CVCs. This is an update of a previously published systematic review (<a href="./references#CD010996-bbs2-0065" title="BradfordNK , EdwardsRM , ChanRJ . Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children. Cochrane Database of Systematic Reviews2015, Issue 11. [DOI: 10.1002/14651858.CD010996.pub2]">Bradford 2015</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010996-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010996-sec-0014"></div> <p>To assess the clinical effects (benefits and harms) of intermittent flushing of normal saline versus heparin to prevent occlusion in long‐term central venous catheters in infants and children. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010996-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010996-sec-0015"></div> <section id="CD010996-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010996-sec-0017"> <h4 class="title">Types of studies</h4> <p>We considered all randomised controlled trials (RCTs) that compared the efficacy of normal saline with heparin for the prevention of occlusion of central venous catheters (CVCs). Due to potential bias, we excluded studies that used alternative methods (quasi‐randomised) to allocate participants to an intervention or control group. </p> </section> <section id="CD010996-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included study populations comprising infants and children aged 0 to 18 years, who had a CVC (tunnelled catheter or totally implanted catheter) inserted for long‐term venous access. Because midline catheters are not placed in the same position as a CVC (superior or inferior vena cava), and PICC have narrow lumens which require specific care, studies of infants or children with midline catheters or PICCs were beyond the scope of this review and we excluded them. We placed no restrictions on the insertion site, or catheter tip placement site (superior or inferior vena cava). We placed no restrictions on the healthcare setting in which the study was conducted, for example tertiary hospital or community setting. Where studies had a mixed population that included infants, children and adults, we included data from infants and children only. If information was not presented in the article, we contacted the study authors to attempt to obtain age‐stratified results. If we were unable to contact the study authors, and children and infants comprised a proportion greater than 20% of the study population, we included the appropriate proportion of participants to represent the paediatric component. If we were unable to obtain any information regarding the proportion of infants and children in the study population, we excluded the study from the review. </p> </section> <section id="CD010996-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included studies where the intervention of interest was the intermittent (any time frequency) flushing of normal saline (alone, or in combination with pulsatile flushing techniques, positive displacement devices or positive pressure lock) compared with intermittent flushing with heparin (any dose or concentration) delivered with the intention to prevent occlusion of the CVC. </p> </section> <section id="CD010996-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>We did not consider outcome measures to be a part of eligibility criteria.</p> <section id="CD010996-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD010996-list-0001"> <li> <p>Occlusion of the CVC, determined by the inability to infuse fluids through the catheter</p> </li> <li> <p>CVC‐associated blood stream infection or colonisation of the catheter (as defined by studies) </p> </li> <li> <p>Duration in days of catheter placement</p> </li> </ul> </p> </section> <section id="CD010996-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD010996-list-0002"> <li> <p>Inability to withdraw blood from the CVC</p> </li> <li> <p>Any use of urokinase or recombinant tissue plasminogen such as alteplase</p> </li> <li> <p>Incidence of removal/re‐insertion of the catheter</p> </li> <li> <p>CVC‐related thrombosis</p> </li> <li> <p>Other CVC‐related complication (e.g. dislocation of CVCs, tunnel or site infection, allergic reaction, haemorrhage, heparin‐induced thrombocytopenia, elevated hepatic enzymes) </p> </li> </ul> </p> </section> </section> </section> <section id="CD010996-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010996-sec-0024"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Vascular Information Specialist conducted systematic searches of the following databases for randomised controlled trials and controlled clinical trials without language, publication year or publication status restrictions. </p> <p> <ul id="CD010996-list-0003"> <li> <p>Cochrane Vascular Specialised Register via the Cochrane Register of Studies (CRS Web searched on 9 April 2019) </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) Cochrane Register of Studies Online (CRSO 2019, 3) </p> </li> <li> <p>MEDLINE (Ovid MEDLINE® Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Ovid MEDLINE® Daily and Ovid MEDLINE®) (searched from 1 January 2017 to 9 April 2019) </p> </li> <li> <p>Embase Ovid (searched from 1 January 2017 to 9 April 2019)</p> </li> <li> <p>CINAHL EBSCO (searched from 1 January 2017 to 9 April 2019)</p> </li> <li> <p>AMED Ovid (searched from 1 January 2017 to 9 April 2019)</p> </li> </ul> </p> <p>The Information Specialist modelled search strategies for other databases on the search strategy designed for CENTRAL. Where appropriate, they were combined with adaptations of the Highly Sensitive Search Strategy designed by Cochrane for identifying randomised controlled trials and controlled clinical trials (as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions,</i> Chapter 6, <a href="./references#CD010996-bbs2-0047" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from handbook.cochrane.org2011.">Lefebvre 2011</a>). Search strategies for major databases are provided in <a href="./appendices#CD010996-sec-0082">Appendix 1</a>. </p> <p>The Information Specialist searched the following trials registries on 9 April 2019.</p> <p> <ul id="CD010996-list-0004"> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (<a href="http://who.int/trialsearch" target="_blank">who.int/trialsearch</a>) </p> </li> <li> <p><a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> </p> </li> </ul> </p> </section> <section id="CD010996-sec-0025"> <h4 class="title">Searching other resources</h4> <p>Two review authors (NB, RE) screened the reference lists of retrieved articles for additional studies. We attempted to contact authors of any studies identified in unpublished literature to obtain further data. </p> </section> </section> <section id="CD010996-sec-0026"> <h3 class="title" id="CD010996-sec-0026">Data collection and analysis</h3> <section id="CD010996-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Two review authors (NB, RE) independently reviewed all titles and abstracts of retrieved articles using Covidence software (<a href="./references#CD010996-bbs2-0031" title="Veritas Health InnovationCovidence. Version accessed 10 April 2019. Melbourne, Australia: Veritas Health Innovation.Available at covidence.org.">Covidence</a>), to assess eligibility against inclusion criteria. When disagreement arose regarding the inclusion of a study, the third author (RC) acted as arbitrator. We obtained the full text of all potentially eligible studies and contacted authors of primary studies to clarify data if necessary. We used a flowchart based upon the PRISMA statement to document results (<a href="./references#CD010996-bbs2-0050" title="MoherD , LiberatiA , TezlaffJ , AltmanDG , The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine2009;151(4):264-9.">Moher 2009</a>). We recorded data on the results of all searches undertaken including database searched, date, limiters, and number of results. We recorded the reasons for exclusion of studies. </p> </section> <section id="CD010996-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (NB, RC) extracted the data independently using the Cochrane Vascular Group forms for dichotomous and continuous data. In the updated review, we also used Covidence to extract data (<a href="./references#CD010996-bbs2-0031" title="Veritas Health InnovationCovidence. Version accessed 10 April 2019. Melbourne, Australia: Veritas Health Innovation.Available at covidence.org.">Covidence</a>). Where available, we collected data regarding the: </p> <p> <ul id="CD010996-list-0005"> <li> <p>lead author and year of study;</p> </li> <li> <p>country where the study was undertaken;</p> </li> <li> <p>participant inclusion criteria;</p> </li> <li> <p>participant age and gender;</p> </li> <li> <p>study design;</p> </li> <li> <p>description of interventions;</p> </li> <li> <p>setting of study;</p> </li> <li> <p>number of participants in each arm;</p> </li> <li> <p>attrition or losses to follow‐up;</p> </li> <li> <p>variables associated with catheter maintenance (e.g. preparation of injectables (pre‐filled or not), caregiver level of education); </p> </li> <li> <p>outcome measures.</p> </li> </ul> </p> <p>We resolved any disagreement regarding data extraction by discussion between all review authors (NB, RE, RC). </p> </section> <section id="CD010996-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed bias within studies using the tool described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> and reported on the following domains: sequence generation; allocation concealment; blinding; incomplete data; selective outcome reporting; and other biases (<a href="./references#CD010996-bbs2-0042" title="HigginsJP , AltmanDG , Sterne JAC editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011b</a>). If necessary, primary authors were contacted to clarify any information. Two review authors (NB, RC) independently undertook the risk of bias assessment. We resolved disagreement regarding the assessment of bias by discussion between review authors (NB, RC). </p> </section> <section id="CD010996-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>As dichotomous outcomes such as occlusion or central‐line‐associated blood stream infection could occur more than once for individual participants (e.g. once in each lumen of a double lumen CVC), we calculated count data per time at risk of outcome (per 1000 catheter days) and reported rate ratios (RR) with 95% confidence intervals (CI). Using section 9.4.8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010996-bbs2-0034" title="DeeksJJ , HigginsJPT , Altman DG editor(s). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S editor(s).Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Deeks 2011</a>), we also calculated the formula for the log of the standard error (SE) for each RR. We used descriptive statistics, including mean differences (MD) with 95% CI, for any continuous data. We planned to report time‐to‐event data as hazard ratios (HR) with 95% CI. We analysed data with Review Manager software (<a href="./references#CD010996-bbs2-0054" title="The Cochrane CollaborationReview Manager Web (RevMan Web). The Cochrane Collaboration, 2019.Available at: revman.cochrane.org.">RevMan Web 2019</a>). </p> </section> <section id="CD010996-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>We identified the unit of analysis in each study at either the patient or the catheter level. We planned to analyse studies separately for different units of analysis. Where results were reported from cluster RCTs, cross‐over trials or repeated measurements of the same outcome, we took the appropriate design effect into consideration to avoid unit of analysis error. </p> </section> <section id="CD010996-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We contacted primary authors of studies to attempt to obtain any missing data. We assessed all data for potential mislabelling and made no assumptions regarding missing data in order to include these in the analysis. Where data were missing and proved to be irretrievable, we excluded them from the analysis. </p> </section> <section id="CD010996-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>Where feasible, we assessed heterogeneity between effect sizes of included studies by visual inspection of forest plots and the Chi² test (P value &lt; 0.05). We planned to describe inconsistency between trials by assessing the I² statistic and the variability between the effect estimates (<a href="./references#CD010996-bbs2-0040" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60.">Higgins 2003</a>), with an I² value of 50% considered to represent substantial heterogeneity (<a href="./references#CD010996-bbs2-0041" title="HigginsJP , Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011) The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011a</a>). Additionally we considered the clinical heterogeneity of studies where the frequency of interventions or catheter type differed between studies. </p> </section> <section id="CD010996-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>Where appropriate, we planned to assess publication bias using funnel plots and Egger's test (<a href="./references#CD010996-bbs2-0035" title="EggerM , SmithGD , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. BMJ1997;315(7109):629-34.">Egger 1997</a>; <a href="./references#CD010996-bbs2-0060" title="SterneJAC , EggerM , Moher D editor(s). Chapter 10: Addressing reporting biases. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Sterne 2011</a>). Additionally, we reduced possible reporting bias by searching multiple electronic databases, proceedings of conferences and scientific meetings, and trial registries. We excluded duplicates of the same trial to avoid duplicate publication bias. </p> </section> <section id="CD010996-sec-0035"> <h4 class="title">Data synthesis</h4> <p>The primary author (NB) entered data into RevMan Web (<a href="./references#CD010996-bbs2-0054" title="The Cochrane CollaborationReview Manager Web (RevMan Web). The Cochrane Collaboration, 2019.Available at: revman.cochrane.org.">RevMan Web 2019</a>), and undertook analysis according to recommended guidelines (<a href="./references#CD010996-bbs2-0034" title="DeeksJJ , HigginsJPT , Altman DG editor(s). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S editor(s).Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Deeks 2011</a>). We planned to combine effect sizes across studies using a fixed‐effect model and CI limits set at 95%. Where substantial heterogeneity existed, we pooled data using the random‐effects model. Where it was not appropriate to combine results, we presented a narrative review descriptively summarising the results. </p> </section> <section id="CD010996-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to conduct subgroup analysis where appropriate with:</p> <p> <ul id="CD010996-list-0006"> <li> <p>type of CVC (tunnelled catheter or implanted port);</p> </li> <li> <p>insertion site or catheter tip placement site, or both;</p> </li> <li> <p>age group;</p> </li> <li> <p>oncology or other diagnosis;</p> </li> <li> <p>use of systemic heparin.</p> </li> </ul> </p> <p>We were unable to do this as data were not available.</p> </section> <section id="CD010996-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to undertake sensitivity analyses to examine the effects of different trials and their methodology including: number of participants (≥ 50 vs &lt; 50 participants); concentration of heparin; and duration of follow‐up. We were unable to do this as data were not available. </p> </section> <section id="CD010996-sec-0038"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We present the main findings of the review results concerning the certainty of evidence, the magnitude of effect of the interventions examined, the sum of available data for the primary outcomes CVC occlusion rate, and CVC‐associated blood stream infection and duration in days of catheter placement in <a href="./full#CD010996-tbl-0001">summary of findings Table 1</a>, according to <a href="./references#CD010996-bbs2-0057" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JP, Green S editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Schünemann 2011</a> and <a href="./references#CD010996-bbs2-0025" title="AtkinsD , BestD , BrissPA , EcclesM , Falck-YtterY , FlottorpS , et al, GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490-4.">Atkins 2004</a>. We used GRADEprofiler (GRADEpro) software to assist in the preparation of the 'Summary of findings' table (<a href="./references#CD010996-bbs2-0038" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 13 September 2019. Hamilton (ON): McMaster University (developed by Evidence Prime).Available at www.gradepro.org.">GRADEpro GDT</a>). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010996-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010996-sec-0039"></div> <section id="CD010996-sec-0040"> <h3 class="title">Description of studies</h3> <section id="CD010996-sec-0041"> <h4 class="title">Results of the search</h4> <p>See <a href="#CD010996-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD010996-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010996-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_n/nCD010996-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>We identified one new study for this update (<a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a>); and included three studies from the previous version (<a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a>; <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a>; <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a>). We excluded 12 new studies (<a href="./references#CD010996-bbs2-0005" title="AraujoO , AraujoM , SilvaJ , BarrosM , . Intermittent heparin is not effective at preventing the occlusion of peripherally inserted central venous catheters in preterm and term neonates. Revista Brasileira de Terapia Intensiva2011;23(3):335-40. ">Arauj 2011</a>; <a href="./references#CD010996-bbs2-0006" title="ArntsIJ , HeijnenJA , WilbersHT , van derWiltGJ , GroenewoudJM , LiemKD , . Effectiveness of heparin solution versus normal saline in maintaining patency of intravenous locks in neonates: a double blind randomized controlled study. Journal of Advanced Nursing2011;67(12):2677-85. ">Arnts 2011</a>; <a href="./references#CD010996-bbs2-0007" title="BritoARO , NishinariK , SaadPF , SaadKR , PereiraMAT , EmidioSCD , et al. Comparison between saline solution containing heparin versus saline solution in the lock of totally implantable catheters. Annals of Vascular Surgery2018;47:85-9. ">Brito 2018</a>; <a href="./references#CD010996-bbs2-0010" title="Heidari GorjiMA , RezaeiF , JafariH , Yazdani CheratiJ . Comparison of the effects of heparin and 0.9% sodium chloride solutions in maintenance of patency of central venous catheters. Anesthesiology and Pain Medicine2015;5(2):e22595. ">Heidari Gorji 2015</a>; <a href="./references#CD010996-bbs2-0012" title="KleinJ , PattersonA , JepsenA , BadgeroK , MooreM , WarrellWA , ThorntonK . Effectiveness of heparin versus saline flushing for managing central venous catheters (CVCs) in the blood and marrow transplant (BMT) patients: a pilot study. Biology of Blood and Marrow Transplantation2017;23(3):S386. ">Klein 2017</a>; <a href="./references#CD010996-bbs2-0013" title="KleinJ , JepsenA , PattersonA , ReichRR , MasonTM . Heparin versus normal saline: flushing effectiveness in managing central venous catheters in patients undergoing blood and marrow transplantation. Clinical Journal of Oncology Nursing2018;22(2):1-5. ">Klein 2018</a>; <a href="./references#CD010996-bbs2-0015" title="NCT01343680. Trial of two central venous catheter (CVC) flushing schemes in pediatric hematology and oncology patients. https://clinicaltrials.gov/show/NCT01343680 (first posted 28 April 2011). ">NCT01343680</a>; <a href="./references#CD010996-bbs2-0014" title="NCT00001518. A randomized evaluation of the effect of routine normal saline flush versus heparinized saline solution in Groshong and Groshong PICC catheters. clinicaltrials.gov/ct2/show/NCT00001518 (first posted December 10 2002). ">NCT00001518</a>; <a href="./references#CD010996-bbs2-0016" title="NCT02354118. Maintaining patency in implanted port catheters. https://clinicaltrials.gov/ct2/show/NCT02354118 (first posted 3 February 2015). ">NCT02354118</a>; <a href="./references#CD010996-bbs2-0017" title="NCT02923830. Maintaining patency in BioFlo implanted port catheters with saline only flushes. https://clinicaltrials.gov/ct2/show/NCT02923830 (first posted 5 October 2016). ">NCT02923830</a>; <a href="./references#CD010996-bbs2-0020" title="ReichardtP , KretzschmarA , BiakhovM , IrwinD , SlabberC , MillerL , et al. A phase III randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of daily low-molecular-weight heparin (dalteparin sodium, fragmin) in preventing catheter-related complications (CRCs) in cancer patients with central venous catheters (CVCs). Journal of Clinical Oncology2002;21:1474. ">Reichardt 2002</a>; <a href="./references#CD010996-bbs2-0021" title="SchallomME , PrenticeD , SonaC , MicekST , SkrupkyLP . Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial. Critical Care Medicine2012;40(6):1820-26. ">Schallom 2012</a>). </p> </section> <section id="CD010996-sec-0042"> <h4 class="title">Included studies</h4> <p>Based on the review of full texts, four studies met eligibility criteria and we have included them in the final updated review (<a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a>; <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a>; <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a>; <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a>) (see Table: <a href="./references#CD010996-sec-0092" title="">Characteristics of included studies</a>). The studies undertaken by <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> and <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> were of medium duration (25 and 23 months respectively) and included follow‐up periods of 14 and six months respectively. The <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> study was a cross‐over study of two time periods, each of three‐and‐a‐half months (total duration seven months) and did not include a follow‐up period. We were not able to ascertain if this study was analysed as paired data or not, and no information was available regarding the first cross‐over period. The <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> study was a dissertation thesis and was undertaken over a period of 180 days without a follow‐up period. All studies had obtained ethical approval from their relevant institutions. </p> <section id="CD010996-sec-0043"> <h5 class="title">Population</h5> <p>The four included trials involved a total of 255 participants, with the majority of participants (203) coming from <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a>. Of the other three studies, <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> contributed 28 participants, <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> contributed 14 participants and <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> 10 participants. <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> and <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> were not trials specific to children; <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> had more participants in the control arm (n = 17) compared to the intervention arm (n = 11); and child participant numbers were balanced between the intervention and control arms in <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a>. All participants had a long‐term central venous catheter (CVC), and were undergoing treatment for haematology or oncology conditions, or undergoing stem cell transplantation. <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> was undertaken in Italy, <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> in Belgium, <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> in Canada and <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> in Brazil. Participants in <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> and <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> had Broviac tunnelled CVCs inserted, <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> participants all had Hickman catheters inserted, whereas all participants in <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> had totally inserted catheters (ports) placed. All studies were undertaken in developed nations in tertiary referral centres, i.e. large hospitals that provide specialist health care after referral from the providers of primary care and secondary care. Both <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> and <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> undertook power size calculations to obtain sample sizes; it is important to note, however, that children comprised only 3.5% of the <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> study population, thus this study was not powered to analyse the results of children separately. <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> was a small study with only 14 participants. <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> recruited only 17 of a planned 100 participants, of which 10 were children aged less than 18 years. </p> </section> <section id="CD010996-sec-0044"> <h5 class="title">Intervention</h5> <p>Participants in all four included studies received standard care except where stated as follows. </p> <p>All included studies involved an intervention arm where normal saline solution was used in place of heparinised saline when the CVC was not being used. As well as changing the type of solution used to flush the CVC, <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> increased the duration between flushes in the intervention arm. Participants in the control arm received standard care with CVCs flushed twice daily. In the intervention arm, the duration between flushes was increased to weekly. Similarly, <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> increased the duration between flushes in the intervention arm compared to standard care from twice per week to weekly. <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> also introduced a positive pressure cap into the intervention arm. These changes confound the interventions so it is not possible to associate outcomes with the use of the solution alone. <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a>  and <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> were the only two studies included in this review where the only difference between the intervention and control arm was the use of normal saline (intervention) or heparin (control) solution to flush the CVC under positive pressure. In <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a>, it was not clear when participants received either solution; participants were inpatients and four syringes were prepared daily with either normal saline or heparin. However there is no information about when these syringes were administered, or if all four were administered each day. The intervention arm in <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> may have received up to four catheter locks of normal saline each day. These catheter locks were administered whenever a catheter was not used. </p> </section> <section id="CD010996-sec-0045"> <h5 class="title">Control</h5> <p>In all studies, participants randomised to the control arm received various concentrations of heparinised saline to flush their CVC. Participants in <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> received 5 mL of 10 units/mL heparinised saline (i.e. 50 units of heparin) twice daily. Participants in <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> received 3 mL of 200 units/mL heparinised saline (i.e. 600 units of heparin) twice weekly. In <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a>, participants in the control arm received maintenance care (normal saline pulsatile flushes after infusions, blood sampling, etc.), and their CVC was flushed with 3 mL of 100 units/mL heparin (i.e. 300 units of heparin) under positive pressure at least every eight weeks when the CVC was not in use. In <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a>, the control arm received up to four syringes daily of 3 mL containing 50 units of heparin per mL (150 units of heparin per syringe). </p> </section> <section id="CD010996-sec-0046"> <h5 class="title">Outcomes</h5> <p>The primary outcome of interest, occlusion of CVC, was measured in all four studies included in this review. In <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a>, occlusion was defined as blockage of the catheter and measured by both echocardiogram to determine thrombus formation and inability to infuse fluids. <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> also recorded CVC‐associated blood stream and exit site infections. Blood stream infections were defined by <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> as the presence of systemic infection and positive blood cultures, and exit site infections were defined as the presence of infection and positive culture from the exit site. <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> defined CVC occlusion as the inability to withdraw blood or infuse fluids, or both. <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> also measured CVC‐associated blood stream infection, CVC mechanical issues and CVC‐related thrombosis. CVC‐associated blood stream infection was defined by <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> as one or more positive blood cultures obtained through the CVC in patients with signs of infection. CVC mechanical issues included dislodgement of the CVC tip or cuff, fracture or accidental CVC self‐removal by the patient; these outcomes were evaluated by visual inspection and chest X‐ray. CVC‐related thrombosis was measured where clinically indicated by ultrasound, computed tomography or magnetic resonance imaging. <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> measured CVC occlusion as a secondary end point, their primary outcome was partial occlusion defined by easy infusion, difficulty withdrawing from CVC. Other secondary outcome measures in <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> were CVC‐associated blood stream infection and other CVC mechanical issues. CVC‐associated blood stream infection was defined by <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> as positive blood cultures from the CVC and peripheral veins, and fever or chills in the absence of other infection sources. CVC mechanical issues encompassed all other functional problems encountered with each access. <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> measured CVC occlusion daily on both lumens of the CVC, defined as the inability to aspirate fluids/blood. If no fluids/blood could be withdrawn following repositioning, normal saline was injected. If there was resistance or pressure present, the CVC was noted as having a partial occlusion. If no fluids could be infused, the CVC was deemed to have a 'complete occlusion' and the lumen involved was then finished in the study. As the lumens of Hickman catheters are independent, the other lumen could remain in the study until it too occluded, or the study ended. As participants could experience outcomes more than once, all studies except <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> reported the number of catheter days that participants in either study arm were at risk of experiencing an outcome. </p> </section> </section> <section id="CD010996-sec-0047"> <h4 class="title">Excluded studies</h4> <p>For this update, 12 studies were excluded as they did not meet the eligibility criteria (<a href="./references#CD010996-bbs2-0005" title="AraujoO , AraujoM , SilvaJ , BarrosM , . Intermittent heparin is not effective at preventing the occlusion of peripherally inserted central venous catheters in preterm and term neonates. Revista Brasileira de Terapia Intensiva2011;23(3):335-40. ">Arauj 2011</a>; <a href="./references#CD010996-bbs2-0006" title="ArntsIJ , HeijnenJA , WilbersHT , van derWiltGJ , GroenewoudJM , LiemKD , . Effectiveness of heparin solution versus normal saline in maintaining patency of intravenous locks in neonates: a double blind randomized controlled study. Journal of Advanced Nursing2011;67(12):2677-85. ">Arnts 2011</a>; <a href="./references#CD010996-bbs2-0007" title="BritoARO , NishinariK , SaadPF , SaadKR , PereiraMAT , EmidioSCD , et al. Comparison between saline solution containing heparin versus saline solution in the lock of totally implantable catheters. Annals of Vascular Surgery2018;47:85-9. ">Brito 2018</a>; <a href="./references#CD010996-bbs2-0010" title="Heidari GorjiMA , RezaeiF , JafariH , Yazdani CheratiJ . Comparison of the effects of heparin and 0.9% sodium chloride solutions in maintenance of patency of central venous catheters. Anesthesiology and Pain Medicine2015;5(2):e22595. ">Heidari Gorji 2015</a>; <a href="./references#CD010996-bbs2-0012" title="KleinJ , PattersonA , JepsenA , BadgeroK , MooreM , WarrellWA , ThorntonK . Effectiveness of heparin versus saline flushing for managing central venous catheters (CVCs) in the blood and marrow transplant (BMT) patients: a pilot study. Biology of Blood and Marrow Transplantation2017;23(3):S386. ">Klein 2017</a>; <a href="./references#CD010996-bbs2-0013" title="KleinJ , JepsenA , PattersonA , ReichRR , MasonTM . Heparin versus normal saline: flushing effectiveness in managing central venous catheters in patients undergoing blood and marrow transplantation. Clinical Journal of Oncology Nursing2018;22(2):1-5. ">Klein 2018</a>; <a href="./references#CD010996-bbs2-0014" title="NCT00001518. A randomized evaluation of the effect of routine normal saline flush versus heparinized saline solution in Groshong and Groshong PICC catheters. clinicaltrials.gov/ct2/show/NCT00001518 (first posted December 10 2002). ">NCT00001518</a>; <a href="./references#CD010996-bbs2-0015" title="NCT01343680. Trial of two central venous catheter (CVC) flushing schemes in pediatric hematology and oncology patients. https://clinicaltrials.gov/show/NCT01343680 (first posted 28 April 2011). ">NCT01343680</a>; <a href="./references#CD010996-bbs2-0016" title="NCT02354118. Maintaining patency in implanted port catheters. https://clinicaltrials.gov/ct2/show/NCT02354118 (first posted 3 February 2015). ">NCT02354118</a>; <a href="./references#CD010996-bbs2-0017" title="NCT02923830. Maintaining patency in BioFlo implanted port catheters with saline only flushes. https://clinicaltrials.gov/ct2/show/NCT02923830 (first posted 5 October 2016). ">NCT02923830</a>; <a href="./references#CD010996-bbs2-0020" title="ReichardtP , KretzschmarA , BiakhovM , IrwinD , SlabberC , MillerL , et al. A phase III randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of daily low-molecular-weight heparin (dalteparin sodium, fragmin) in preventing catheter-related complications (CRCs) in cancer patients with central venous catheters (CVCs). Journal of Clinical Oncology2002;21:1474. ">Reichardt 2002</a>; <a href="./references#CD010996-bbs2-0021" title="SchallomME , PrenticeD , SonaC , MicekST , SkrupkyLP . Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial. Critical Care Medicine2012;40(6):1820-26. ">Schallom 2012</a>). Six studies were excluded from the previous version (<a href="./references#CD010996-bbs2-0008" title="De NeefM , HeijboerH , Van WoenselJB , De HaanRJ . The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial. Pediatric Hematology and Oncology2002;19(8):553-60. ">De Neef 2002</a>; <a href="./references#CD010996-bbs2-0009" title="GeritzMA . Saline versus heparin in intermittent infuser patency maintenance. Western Journal of Nursing Research1992;14(2):131-7. ">Geritz 1992</a>; <a href="./references#CD010996-bbs2-0011" title="KanekoY , IwanoM , YoshidaH , KosugeM , ItoS , NaritaI , et al. Natural saline-flush is sufficient to maintain patency of immobilized-urokinase double-lumen catheter used to provide temporary blood access for hemodialysis. Blood Purification2004;22(5):473-9. ">Kaneko 2004</a>; <a href="./references#CD010996-bbs2-0018" title="PumarolaC , Casademont MercaderR , Colomer PlanaM , Cordon BuenoC , Sabench CasellasS , Felez VidalM , et al. Comparative study of maintenance of patency of triple lumen central venous catheter [Estudio comparativo del mantenimiento de la permeabilidad de los cateteres venosos centrales de tres luces]. Enfermeria Intensiva2007;18(1):25-35. ">Pumarola 2007</a>; <a href="./references#CD010996-bbs2-0019" title="RabeC , GramannT , SonsX , BernaM , Gonzalez-CarmonaMA , KlehrHU , et al. Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients. Intensive Care Medicine2002;28(8):1172-6. ">Rabe 2002</a>; <a href="./references#CD010996-bbs2-0022" title="SchultzAA , DrewD , HewittH . Comparison of normal saline and heparinized saline for patency of IV locks in neonates. Applied Nursing Research2002;15(1):28-34. ">Schultz 2002</a>), making a total of 18 excluded studies. Most studies were excluded because they were adult studies with no children (<a href="./references#CD010996-bbs2-0005" title="AraujoO , AraujoM , SilvaJ , BarrosM , . Intermittent heparin is not effective at preventing the occlusion of peripherally inserted central venous catheters in preterm and term neonates. Revista Brasileira de Terapia Intensiva2011;23(3):335-40. ">Arauj 2011</a>; <a href="./references#CD010996-bbs2-0006" title="ArntsIJ , HeijnenJA , WilbersHT , van derWiltGJ , GroenewoudJM , LiemKD , . Effectiveness of heparin solution versus normal saline in maintaining patency of intravenous locks in neonates: a double blind randomized controlled study. Journal of Advanced Nursing2011;67(12):2677-85. ">Arnts 2011</a>; <a href="./references#CD010996-bbs2-0010" title="Heidari GorjiMA , RezaeiF , JafariH , Yazdani CheratiJ . Comparison of the effects of heparin and 0.9% sodium chloride solutions in maintenance of patency of central venous catheters. Anesthesiology and Pain Medicine2015;5(2):e22595. ">Heidari Gorji 2015</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1511201019468709487599206600785&amp;format=REVMAN#STD-Kaneko-2004" target="_blank">Kaneko 2004</a>; <a href="./references#CD010996-bbs2-0012" title="KleinJ , PattersonA , JepsenA , BadgeroK , MooreM , WarrellWA , ThorntonK . Effectiveness of heparin versus saline flushing for managing central venous catheters (CVCs) in the blood and marrow transplant (BMT) patients: a pilot study. Biology of Blood and Marrow Transplantation2017;23(3):S386. ">Klein 2017</a>; <a href="./references#CD010996-bbs2-0013" title="KleinJ , JepsenA , PattersonA , ReichRR , MasonTM . Heparin versus normal saline: flushing effectiveness in managing central venous catheters in patients undergoing blood and marrow transplantation. Clinical Journal of Oncology Nursing2018;22(2):1-5. ">Klein 2018</a>; <a href="./references#CD010996-bbs2-0014" title="NCT00001518. A randomized evaluation of the effect of routine normal saline flush versus heparinized saline solution in Groshong and Groshong PICC catheters. clinicaltrials.gov/ct2/show/NCT00001518 (first posted December 10 2002). ">NCT00001518</a>; <a href="./references#CD010996-bbs2-0015" title="NCT01343680. Trial of two central venous catheter (CVC) flushing schemes in pediatric hematology and oncology patients. https://clinicaltrials.gov/show/NCT01343680 (first posted 28 April 2011). ">NCT01343680</a>; <a href="./references#CD010996-bbs2-0016" title="NCT02354118. Maintaining patency in implanted port catheters. https://clinicaltrials.gov/ct2/show/NCT02354118 (first posted 3 February 2015). ">NCT02354118</a>; <a href="./references#CD010996-bbs2-0017" title="NCT02923830. Maintaining patency in BioFlo implanted port catheters with saline only flushes. https://clinicaltrials.gov/ct2/show/NCT02923830 (first posted 5 October 2016). ">NCT02923830</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1511201019468709487599206600785&amp;format=REVMAN#STD-Rabe-2002" target="_blank">Rabe 2002</a>; <a href="./references#CD010996-bbs2-0020" title="ReichardtP , KretzschmarA , BiakhovM , IrwinD , SlabberC , MillerL , et al. A phase III randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of daily low-molecular-weight heparin (dalteparin sodium, fragmin) in preventing catheter-related complications (CRCs) in cancer patients with central venous catheters (CVCs). Journal of Clinical Oncology2002;21:1474. ">Reichardt 2002</a>; <a href="./references#CD010996-bbs2-0021" title="SchallomME , PrenticeD , SonaC , MicekST , SkrupkyLP . Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial. Critical Care Medicine2012;40(6):1820-26. ">Schallom 2012</a>). One study was not a RCT (<a href="./references#CD010996-bbs2-0007" title="BritoARO , NishinariK , SaadPF , SaadKR , PereiraMAT , EmidioSCD , et al. Comparison between saline solution containing heparin versus saline solution in the lock of totally implantable catheters. Annals of Vascular Surgery2018;47:85-9. ">Brito 2018</a>); and one study was terminated after recruiting only two participants (<a href="./references#CD010996-bbs2-0015" title="NCT01343680. Trial of two central venous catheter (CVC) flushing schemes in pediatric hematology and oncology patients. https://clinicaltrials.gov/show/NCT01343680 (first posted 28 April 2011). ">NCT01343680</a>). <a href="https://archie.cochrane.org/sections/documents/view?version=z1511201019468709487599206600785&amp;format=REVMAN#STD-Geritz-1992" target="_blank">Geritz 1992</a> and <a href="https://archie.cochrane.org/sections/documents/view?version=z1511201019468709487599206600785&amp;format=REVMAN#STD-Schultz-2002" target="_blank">Schultz 2002</a> reported trials investigating peripheral catheters; <a href="https://archie.cochrane.org/sections/documents/view?version=z1511201019468709487599206600785&amp;format=REVMAN#STD-De-Neef-2002" target="_blank">De Neef 2002</a> and <a href="https://archie.cochrane.org/sections/documents/view?version=z1511201019468709487599206600785&amp;format=REVMAN#STD-Kaneko-2004" target="_blank">Kaneko 2004</a> investigated arterial catheters; and <a href="https://archie.cochrane.org/sections/documents/view?version=z1511201019468709487599206600785&amp;format=REVMAN#STD-Pumarola-2007" target="_blank">Pumarola 2007</a> and <a href="https://archie.cochrane.org/sections/documents/view?version=z1511201019468709487599206600785&amp;format=REVMAN#STD-Rabe-2002" target="_blank">Rabe 2002</a> investigated temporary central venous catheters. See <a href="./references#CD010996-sec-0093" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD010996-sec-0048"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD010996-fig-0002">Figure 2</a>, <a href="#CD010996-fig-0003">Figure 3</a> and <a href="./references#CD010996-sec-0092" title="">Characteristics of included studies</a>. </p> <div class="figure" id="CD010996-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010996-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_n/nCD010996-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010996-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010996-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_n/nCD010996-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010996-sec-0049"> <h4 class="title">Allocation</h4> <p>There was low risk of selection bias in the <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a>, <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> and <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> studies; these investigators reported using computerised random sequencing and concealing allocation until participants had been recruited and provided consent. <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> did not provide any details regarding how participants were randomised and we therefore judged it to be of unclear risk of selection bias. </p> </section> <section id="CD010996-sec-0050"> <h4 class="title">Blinding</h4> <p><a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> was the only study that reported blinding participants, clinicians and researchers to which arm the participant was allocated and we deemed it to have low risk for performance bias and detection bias. <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> stated blinding was not possible for logistical reasons. All outcomes were objectively measured, but in <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a>, <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> and <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> there is the possibility clinicians may have modified their technique depending on the arm to which the participant had been allocated. We therefore assessed these three studies at high risk of both performance and detection bias. </p> </section> <section id="CD010996-sec-0051"> <h4 class="title">Incomplete outcome data</h4> <p>All four studies included in this review reported full results for all participants who were randomised. A flowchart of participant progress through the study was provided by <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a>. There were no protocol violations reported by <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> or <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a>. In <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> there was a 4.9% dropout rate which was not statistically different between the two groups and all analysis was based on intention to treat. This dropout rate relates to the adult participants and not the children included in this review. In <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a>, 22% (n = 44) of CVCs required premature removal; there were, however, no statistical differences between study arms. Attrition of two participants due to death also occurred in this study but no losses to follow‐up occurred. <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> and <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> reported no losses to follow‐up. We assigned <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a>, <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> and <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> a low risk of attrition bias, and <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> an unclear risk. </p> </section> <section id="CD010996-sec-0052"> <h4 class="title">Selective reporting</h4> <p>All studies reported on their primary and secondary outcome measures. There was a study protocol for <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a>; we therefore deemed risk of reporting bias for this study to be low. Neither <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> nor <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> had a published protocol and so we deemed them at unclear risk. <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> reported data in a basic format with no results from statistical tests. It is not clear if paired analysis was undertaken; we assessed this study as being at high risk for reporting bias. </p> </section> <section id="CD010996-sec-0053"> <h4 class="title">Other potential sources of bias</h4> <p>In both the <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> and <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> studies, there is a high concern for confounding of results. Both these studies altered the frequency between flushes for the intervention arm as well as the concentration of the heparin solution. Additionally, the intervention arm included the use of a positive pressure cap in <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a>. It is not possible therefore to attribute the outcome to the use of the solution alone: the outcome could plausibly also be attributed to the frequency of flushes or the use of a positive pressure cap. It may therefore be more appropriate to view the intervention as a component of a bundle of care. Further bias may exist in the subset of unpublished data of paediatric participants provided by <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a>; we were not able to determine if the characteristics of this subset of participants were subject to other biases. As it is a cross‐over study, there may have been a carry‐over effect of the intervention from one arm to the other in <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a>. It is not clear if the study authors considered this. <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> recruited only 17 of a planned 100 participants: this small sample size reduced precision of the findings. Additionally it was not clear how long participants remained in the study. These other potential sources of bias across all four studies are substantial and they are all at high risk of bias for this domain. </p> </section> </section> <section id="CD010996-sec-0054"> <h3 class="title" id="CD010996-sec-0054">Effects of interventions</h3> <p>See: <a href="./full#CD010996-tbl-0001"><b>Summary of findings 1</b> Does normal saline flushing in long‐term central venous catheters (CVC) prevent occlusion compared to heparin flushing in infants and children?</a> </p> <p>See <a href="./full#CD010996-tbl-0001">summary of findings Table 1</a> for the three primary outcomes: CVC occlusion; CVC‐associated blood stream infection or colonisation; and duration in days of catheter placement. See Additional <a href="#CD010996-tbl-0002">Table 1</a> for summary of outcome rates per 1000 catheter days. </p> <div class="table" id="CD010996-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Rate per 1000 catheter days for primary and secondary outcomes</span></div> <tbody> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. "><b>Smith 1991</b> </a> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. "><b>Cesaro 2009</b> </a> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. "><b>Goossens 2013</b> </a> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Outcome</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Normal saline</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heparin</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Normal saline</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heparin</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Normal saline</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heparin</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CVC occlusion rate per 1000 catheter days</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.32</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.66</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.16</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.11</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.62</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.35</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CVC‐associated blood stream infection rate per 1000 catheter days</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.32</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.66</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.62</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.24</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.32</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.04</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inability to withdraw blood</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.42</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CVC dislodgement</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.65</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.47</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.54</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CVC site infection</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.31</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.26</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.38</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CVC‐related thrombosis</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.66</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.66</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.30</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.30</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CVC: Central venous catheter</p> <p><a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> not included in table as rate per 1000 catheter days not able to be calculated </p> </div> </div> <p>We were not able to ascertain if <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> analysed data as paired data or not, and no information was available regarding the first cross‐over period. We were not able to obtain data regarding the child participants in <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a>, or information regarding the number of catheter days. We therefore did not pool results from these two studies with the others. </p> <section id="CD010996-sec-0055"> <h4 class="title">Primary outcomes</h4> <section id="CD010996-sec-0056"> <h5 class="title">CVC occlusion</h5> <p>CVC occlusion was reported in all four included trials (253 participants; <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> provided data for 26 of 28 participants for CVC occlusion). <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> and <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> provided information regarding the number of catheter days for each arm of their study. <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> provided the mean catheter days for each arm of the total population in their study (i.e. including both the child and adult participants). <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> provided data specific to children; this did not, however, include disaggregate data regarding the number of mean catheter days. We assumed that the mean number of catheter days for the child participants in each study arm was comparable to that of the adult participants. Based on this information, we calculated the occlusion rate ratio (RR) for the intervention arm (normal saline) versus the control arm (heparin) for each study per 1000 catheter days. In <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a>, <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> and <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a>, there were more CVC occlusions in the intervention (normal saline) arm. The RR of CVC occlusion in <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> was 2.0 (95% CI 0.18 to 21.85), and in <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> the RR was 1.95 (95% CI 1.34 to 2.83). Because of absent data regarding the first period in the cross‐over study design used in <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a>, we did not pool results from this study. </p> <p>We were unable to calculate a RR for <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> as there was no information about number of catheter days. We therefore could not pool data for analysis. This study reported survival analysis for each lumen and reported fewer occlusions in the control arm (heparin) compared to the intervention arm (normal saline); in the white lumen for all participants, both children and adults, the mean number of days until occlusion for normal saline was 52 (95% CI 42.92 to 61.07) versus for heparin 13.46 (95% CI 8.16 to 18.77; P &lt; 0.001); and in red lumen for normal saline 35.29 (95% CI 25.59 to 44.98) versus for heparin 22.3 (95% CI 12.42 to 32.18; P = 0.03).  In children less than 18 years of age, in the intervention group (normal saline, n = 5) all participants experienced an occlusion in at least one lumen compared to the control group (heparin, n = 5) where only one child experienced occlusion in one lumen.  These results for child participants were reported by <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> but were not formally assessed.  </p> <p><a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> found there were fewer CVC occlusions in the intervention (normal saline) arm; the RR was 0.25 (95% CI 0.09 to 0.73). </p> <p>When we pooled the results from the <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> and <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> studies, the heterogeneity was substantial (I² = 92%); we therefore chose a random‐effects model to estimate the combined effect. Combined analysis suggested there was no clear benefit in the outcome of CVC occlusion between flushing with heparin or normal saline (RR 0.75, 95% CI 0.10 to 5.51; 2 studies, 229 participants; P = 0.78). Heterogeneity between studies indicates this result may be due to differences between the studies. See <a href="./references#CD010996-fig-0004" title="">Analysis 1.1</a>. We downgraded the certainty of the evidence to very low (see <a href="./full#CD010996-tbl-0001">summary of findings Table 1</a>). </p> </section> <section id="CD010996-sec-0057"> <h5 class="title">CVC‐associated blood stream infection or colonisation</h5> <p>Incidence of CVC‐associated blood stream infection was reported in three included trials (245 participants) (<a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a>; <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a>; <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a>). As described above, we calculated RR for each study based upon 1000 catheter days. There were more CVC‐associated blood stream infections in the intervention (normal saline) arm in both <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> and <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a>. The RR in <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> was 2.00 (95% CI 0.18 to 21.85); in <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> the RR was 2.58 (95% CI 1.20 to 5.54). In <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a>, there were no incidences of infection in the intervention (normal saline) arm; therefore to calculate the log of the standard error for the rate ratio, as per section 9.4.8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>, we added 0.5 to each arm of the study (<a href="./references#CD010996-bbs2-0034" title="DeeksJJ , HigginsJPT , Altman DG editor(s). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S editor(s).Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Deeks 2011</a>). The resulting calculation in <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> was a RR of 0.30 (95% CI 0.01 to 6.26). Because of absent data regarding the first period in the cross‐over study design used in <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a>, we did not pool results from this study. We pooled the results of <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> and <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a>. The heterogeneity between studies was I² = 45%. Because the I² statistic approached 50% and there was also evidence of clinical heterogeneity between the studies, (e.g. difference in frequency of flushing, implanted catheters and tunnelled catheters, use of positive pressure cap) we used the random‐effects model. See <a href="./references#CD010996-fig-0005" title="">Analysis 1.2</a>. There is no clear difference between the use of saline to flush CVCs and the incidence of CVC‐associated blood stream infection (RR 1.48, 95% CI 0.24 to 9.37; 2 studies, 231 participants; P = 0.67). We downgraded the certainty of the evidence to low (see <a href="./full#CD010996-tbl-0001">summary of findings Table 1</a>). </p> </section> <section id="CD010996-sec-0058"> <h5 class="title">Duration of CVC placement (days)</h5> <p>Duration of CVC placement was not reported in <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a>, <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a>, and <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a>. <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> reported survival data rather than duration of CVC placement in days. We report the survival data below. </p> <p>After a median follow‐up of 360 days, <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> reported that CVC survival was similar between the two study arms (203 participants). In the intervention (normal saline) arm mean survival was reported as 77% (95% CI 66% to 84%); and in the control (heparin) arm mean survival was reported as 69% (95% CI 53% to 80%). We downgraded the certainty of evidence to moderate (see  <a href="./full#CD010996-tbl-0001">summary of findings Table 1</a>). </p> </section> </section> <section id="CD010996-sec-0059"> <h4 class="title">Secondary outcomes</h4> <section id="CD010996-sec-0060"> <h5 class="title">Inability to withdraw blood from the CVC</h5> <p><a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> reported on the inability to withdraw blood from the CVC (26 participants). Compared to the intervention (normal saline) group, there was a decreased inability to withdraw blood from the CVC in the heparin group (RR 0.32, 95% CI 0.14 to 0.88). <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a>, <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> and <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> did not report on the inability to withdraw blood from the CVC. </p> </section> <section id="CD010996-sec-0061"> <h5 class="title">Any use of urokinase or recombinant tissue plasminogen</h5> <p>Urokinase was used in 116 of 124 (94%) episodes of CVC occlusion in the <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> study of 203 patients, and patency was restored in 107 out of 116 (92%). No specific information was available regarding which treatment arm urokinase was used in and the subsequent result; it is noted, however, that 83 CVCs occluded in the normal saline group and 41 in the heparin group. Five of the CVCs were occluded in only one lumen and so were left in situ while the remaining four were unable to have patency restored in either lumen and were prematurely removed. There was no information available regarding the use of urokinase or other drugs to restore patency in <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a>, <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> and <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a>. </p> </section> <section id="CD010996-sec-0062"> <h5 class="title">Incidence of removal/re‐insertion of the catheter</h5> <p><a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> reported premature removal of a CVC was required in 44 participants, 22% of the total study population of 203 patients. Premature removal was comparable between the two study arms — 21 in the saline arm and 23 in the heparin arm — and was generally indicated because of dislocation of the catheter or infection, rather than CVC occlusion. There was no information regarding this outcome from <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a>, <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> and <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a>. </p> </section> <section id="CD010996-sec-0063"> <h5 class="title">CVC‐related thrombosis</h5> <p>CVC‐related thrombosis was reported in two out of 203 (1%) of the study population in <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> with no differences between study arms (RR 1.00, 95% CI 0.06 to 15.86). In <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a>, CVC‐related thrombosis was reported in two out of 14 (14%) of the population; again there was no difference between study arms (RR 1.00, 95% CI 0.06 to 15.86). </p> </section> <section id="CD010996-sec-0064"> <h5 class="title">Other CVC‐related complications</h5> <p>Dislodgment of the CVC occurred in 38 out of 203 (19%) of the total study population in <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a>. There were no differences between study arms (RR 0.87, 95% CI 0.46 to 1.63). In <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a>, dislodgement occurred in two out of 14 (14%) of the study population. There was no difference between study arms (RR 0.20, 95% CI 0.01 to 4.81). There was no information regarding this outcome available from <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> or <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a>. </p> <p>CVC site infection was reported in 24 out of 203 (12%) in <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> with no differences between study arms (RR 0.68, 95% CI 0.30 to 1.52). In <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a>, CVC site infection was reported in six out of 28 (21%) of the study population; again there was no difference between study arms (RR 7.00, 95% CI 0.37 to 132.40). </p> <p>There were no data available from <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> regarding other CVC complications in the paediatric population of 28 patients, or from <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a>. </p> </section> </section> <section id="CD010996-sec-0065"> <h4 class="title">Subgroup analysis</h4> <p>As there were only four studies included in this review, we were not able to undertake any subgroup analysis. </p> </section> <section id="CD010996-sec-0066"> <h4 class="title">Sensitivity analysis</h4> <p>Due to the limited number of studies in this review, it was not appropriate to undertake a sensitivity analysis. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010996-sec-0067" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010996-sec-0067"></div> <section id="CD010996-sec-0068"> <h3 class="title" id="CD010996-sec-0068">Summary of main results</h3> <p>This updated systematic review compared the use of 0.9% sodium chloride (normal saline) locks with heparin locks and includes four studies with inconsistent results. The outcomes of interest were: central venous catheter (CVC) occlusion; CVC‐associated blood stream infection; duration in days of catheter placement; inability to withdraw blood from the CVC; use of urokinase or recombinant tissue plasminogen; incidence of removal or re‐insertion of the CVC, or both; thrombosis associated with CVC; other CVC‐related complications such as dislocation of the CVC, other CVC infection, allergic reaction, haemorrhage, heparin‐induced thrombocytopenia, and elevated hepatic enzymes. We calculated rate ratios for outcome measures to estimate the probability of each event occurring in each treatment arm. See <a href="./full#CD010996-tbl-0001">summary of findings Table 1</a> for details on the primary outcomes 'CVC occlusion', 'CVC‐associated blood stream infection' and 'Duration in days of catheter placement'. The quantity of available evidence was small: for this updated review we found only one small additional study, and it did not change the original conclusions. We found that there is insufficient data to determine the effects of intermittent flushing of normal saline versus heparin to prevent CVC occlusion or CVC‐associated blood stream infection in infants and children. The use of a positive pressure cap in <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> may have biased the results of this study regarding the outcome of CVC‐associated blood stream infection: there is evidence of an association between the use of a positive pressure cap and CVC‐associated blood stream infection in other studies (<a href="./references#CD010996-bbs2-0043" title="JacobsBR , SchillingS , DoellmanD , HutchinsonN , RickeyM , NelsonS . Central venous catheter occlusion: a prospective controlled trial examining the impact of a positive pressure valve device. Journal of Parenteral and Enteral Nutrition2004;28(2):113-8.">Jacobs 2004</a>; <a href="./references#CD010996-bbs2-0044" title="JarvisWR , MurphyC , HallKK , FoglePJ , KarchmerTB , HarringtonG , et al. Health care-associated bloodstream infections associated with negative- or positive-pressure or displacement mechanical valve needleless connectors. Clinical Infectious Diseases2009;49(12):1821-7.">Jarvis 2009</a>; <a href="./references#CD010996-bbs2-0049" title="MarschallJ , MermelLA , ClassenD , AriasKM , PodgornyK , AndersonD , et al. Strategies to prevent central-line associated infections in acute care hospitals. Strategies2008;29(S1):S22-S30.">Marschall 2008</a>). The certainty and strength of the evidence for the use of normal saline instead of heparin for the routine management of CVC is moderate to very low and further well‐designed studies are required. </p> </section> <section id="CD010996-sec-0069"> <h3 class="title" id="CD010996-sec-0069">Overall completeness and applicability of evidence</h3> <p>The trials included in the review directly compared the use of normal saline and heparin in long‐term CVCs in children in community and acute settings, and we were able to undertake two meta‐analyses. All studies included participants representative of those usually found in the clinical setting. Between studies, however, all used different protocols for the intervention and control arms with different concentrations of heparin and different frequencies of flushes reported. Additionally, within studies, <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> and <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> changed not only the solution being used, but also the frequency of flushes. Any difference seen could therefore be plausibly attributed to either the solution or the frequency of flushes; changing the frequency of flushes may actually confound the results towards the null hypothesis. </p> <p>The four included studies employed a pragmatic approach to assess the effectiveness of saline in routine care (<a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a>; <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a>; <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a>; <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a>). While this approach is desirable to inform policy and routine practice, greater emphasis is required to minimise bias and confounding in the study design to ensure generalisibility. As there are concerns with the internal validity of all studies, the generalisibility (external validity) of results from the studies included in the review is poor. </p> </section> <section id="CD010996-sec-0070"> <h3 class="title" id="CD010996-sec-0070">Quality of the evidence</h3> <section id="CD010996-sec-0071"> <h4 class="title">Study methodology</h4> <p>There was a high level of clinical heterogeneity between all four studies. We summarised the assessment of bias for all studies using Cochrane's 'Risk of bias' tool (<a href="#CD010996-fig-0002">Figure 2</a> and <a href="#CD010996-fig-0003">Figure 3</a>) and indicated methodological weaknesses in all studies. Because of the nature of the outcomes (occlusion, infection, duration of catheter days), a lack of blinding may have impacted the outcome assessment. It could be argued that, if the frequency of flushes had been kept consistent between the intervention and control arms, greater care could have been taken to blind the intervention from both participants and clinicians. As clinicians could potentially modify their technique when assessing for occlusion, blinding allocation to the intervention reduces risk. The <a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> study was the only one to undertake blinding of the intervention. Other concerns across all studies included the potential for selection bias, selective reporting bias, imprecision and possible confounding of results. </p> <p><a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a> in particular is subject to high levels of uncertainty regarding its precision. This study was undertaken many years ago and is reported with minimal detail. It is unclear how the data were analysed (i.e. paired or un‐paired), or if individual participants experienced more than one outcome. Following this study, the institution where the study was conducted changed its practice, replacing heparin with normal saline locks. Recent communication with this institution confirmed that the facility continues to routinely use normal saline locks for long‐term CVCs in children over 12 months of age, providing strong support for the study's findings (<a href="./references#CD010996-bbs2-0039" title="Education Department McMaster Children's Hospital. Protocol for CVC maintenance [personal communication]. Email to: HHS-education@HHSC.CA 29 May 2014.">HHSC 2014 [pers comm]</a>). Therefore despite the bias evident in this study, it is important to consider the clinical implications of the experience of the efficacy of normal saline locks in long‐term CVCs over two decades. </p> <p>In <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a>, the randomisation process is well reported and the study is methodologically sound. However there are concerns regarding the potential for outcomes to be attributed to the positive pressure cap, or the frequency of flushes (or a combination of both) and so it is unclear what role the flushing solution plays. </p> <p><a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> did not intend for the subset of paediatric data to be analysed separately; their study included a large number of adults and only a small proportion of children (28/802, 3.5%). As a consequence, not all the information required to make an assessment of the quality of the study was available. </p> <p><a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> is a dissertation, undertaken by one investigator, and while the study protocol is reported, the study did not recruit as many participants as was intended, and results are reported with minimal analysis. Ten of the 17 recruited participants were children; we were unable, however, to obtain data about these participants or the number of catheter days. The small number of participants reduced the precision of the study findings. </p> </section> <section id="CD010996-sec-0072"> <h4 class="title">Heterogeneity, inconsistency and imprecision of results</h4> <p>When we combined two studies to assess the effect of normal saline on CVC occlusion, the statistical heterogeneity was high (<a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a>; <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a>). The combined results of both CVC occlusion and CVC‐associated blood stream infection revealed wide confidence intervals which included the null hypothesis (<a href="./references#CD010996-fig-0004" title="">Analysis 1.1</a>; <a href="./references#CD010996-fig-0005" title="">Analysis 1.2</a>). The studies do not appear to provide consistent information and we were unable to determine the precision of the studies. The small sample sizes and the few events in the two studies are likely the cause of this heterogeneity. </p> </section> <section id="CD010996-sec-0073"> <h4 class="title">Overall certainty</h4> <p>We assessed the overall certainty of the evidence as very low to low using the GRADE assessment tool; there was a high risk of performance and detection bias in the majority of the studies as well as a high risk of other bias related to differences in frequency of flushes between heparin and saline groups in <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> and <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a>. We also assumed a high risk of other bias for the subset of unpublished paediatric data provided for <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a>. In addition we identified heterogeneity, imprecision and inconsistency of the effect estimates (<a href="./full#CD010996-tbl-0001">summary of findings Table 1</a>). Consequently, the results of these meta‐analyses should be interpreted with caution. Further research is likely to improve the confidence in the estimate of these effects if undertaken with greater attention to methodology. </p> </section> </section> <section id="CD010996-sec-0074"> <h3 class="title" id="CD010996-sec-0074">Potential biases in the review process</h3> <p>None of the review authors were investigators in any of the studies included in this review. The literature review was thorough and the methodology transparent and can be reproduced. None of the review authors have any conflicts of interest to declare. While we attempted to minimise bias in this review as described above, we are aware that there are differing practices worldwide and there may be unpublished studies which we did not include in this review. The review authors made assumptions with the paediatric data provided in the <a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. ">Goossens 2013</a> study that the subset of paediatric patients had the same catheter days at risk as reported in the larger study; these assumptions may have introduced bias in the review process. We originally defined the study population as children and infants aged 1 to 18 years. The included studies had recruited children from age 0 to 20 years: accordingly we changed our study population to include these ages as there were not enough data available to exclude children aged under 1 year in <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> or over 18 years in <a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. ">Smith 1991</a>; we made the assumption this was unlikely to affect the results. </p> </section> <section id="CD010996-sec-0075"> <h3 class="title" id="CD010996-sec-0075">Agreements and disagreements with other studies or reviews</h3> <p>A recent systematic review concurred with our findings that there is insufficient evidence to support the use of normal saline to prevent CVC occlusion (<a href="./references#CD010996-bbs2-0030" title="ConwayMA , McCollomC , BannonC . Central venous catheter flushing recommendations: a systematic evidenced-based practice review. Journal of Pediatric Oncology Nursing2014;31(4):185-90.">Conway 2014</a>). This review included studies related to the adult population and also peripherally inserted CVCs. <a href="./references#CD010996-bbs2-0030" title="ConwayMA , McCollomC , BannonC . Central venous catheter flushing recommendations: a systematic evidenced-based practice review. Journal of Pediatric Oncology Nursing2014;31(4):185-90.">Conway 2014</a> concluded with recommendations for daily flushing with heparin based on the practices of selected facilities. There is insufficient evidence to make this recommendation, however, and it may lead to higher amounts of heparin being used than is necessary, introducing avoidable costs and risks associated with the use of heparin in this patient group. Peripherally inserted CVCs have a much narrower lumen and require different care and thus were excluded from this Cochrane Review. </p> <p>Evidence is emerging to support the use of ethanol locks in children to prevent blood stream infection associated with tunnelled CVC; a randomised trial of 307 children found ethanol locks were safe and had a 50% statistically significant reduction in infection compared to heparin (<a href="./references#CD010996-bbs2-0055" title="SchootRA , vanOmmenCH , StijnenT , TissingWJE , MichielsE , AbbinkFCH , et al. Prevention of central venous catheter-associated bloodstream infections in paediatric oncology patients using 70% ethanol locks: a randomised controlled multi-centre trial. European Journal of Cancer2015;51(14):2031-8.">Schoot 2015</a>). Ethanol was, however, associated with transient symptoms of nausea, taste alterations, dizziness and blushing. </p> <p>A RCT in adults was undertaken by <a href="./references#CD010996-bbs2-0032" title="Dal MolinA , ClericoM , BacciniM , GuerrettaL , SartorelloB , RaseroL . Normal saline versus heparin solution to lock totally implanted venous access devices: results from a multicentred randomized trial. European Journal of Oncology Nursing2015;19(6):638-43.">Dal Molin 2015</a> and included 430 participants with totally implanted venous access devices. This large study failed to demonstrate heparin was superior to normal saline and concluded that the use of heparin continues to be controversial. Similarly, in a smaller trial of 30 adults with tunnelled CVCs normal saline was reported to be safe and effective, and using heparin provided no additional benefit (<a href="./references#CD010996-bbs2-0013" title="KleinJ , JepsenA , PattersonA , ReichRR , MasonTM . Heparin versus normal saline: flushing effectiveness in managing central venous catheters in patients undergoing blood and marrow transplantation. Clinical Journal of Oncology Nursing2018;22(2):1-5. ">Klein 2018</a>). The updated Cochrane Review for adults, <a href="./references#CD010996-bbs2-0048" title="Lopez-BrizE , Ruiz GarciaV , CabelleJB , Bort-MartiS , Carbonell SanchisR , BurlsA . Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults. Cochrane Database of Systematic Reviews2018, Issue 7. [DOI: 10.1002/14651858.CD008462.pub3]">Lopez‐Briz 2018</a>, also found no clear evidence to support the use of heparin to prevent occlusions; while there were fewer occlusions with heparin, the evidence was of very low quality. There was no evidence to suggest heparin was superior to normal saline for CVC‐related sepsis, mortality, haemorrhage, or heparin‐induced thrombocytopenia. </p> <p>There are numerous observational studies that investigate this issue (<a href="./references#CD010996-bbs2-0029" title="BowersL , Gabel SperoniK , JonesL , AthertonM . Comparison of occlusion rates by flushing solutions for peripherally inserted central venous catheters with positive pressure Luer-activated devices. Journal of Infusion Nursing2008;31(1):22-7.">Bowers 2008</a>; <a href="./references#CD010996-bbs2-0007" title="BritoARO , NishinariK , SaadPF , SaadKR , PereiraMAT , EmidioSCD , et al. Comparison between saline solution containing heparin versus saline solution in the lock of totally implantable catheters. Annals of Vascular Surgery2018;47:85-9. ">Brito 2018</a>; <a href="./references#CD010996-bbs2-0036" title="FratinoG , MolinariAC , ParodiS , LongoS , SaraccoP , CastagnolaE , et al. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Annals of Oncology2005;16(4):648-54.">Fratino 2005</a>). Many of these studies support the use of normal saline for routine flushing of long‐term CVCs (<a href="./references#CD010996-bbs2-0023" title="AbateME , Escobosa-SanchezO , BoschiR , RaspantiC , LoroL , AffinitoD , et al. Analysis of risk factors for central venous catheters related complications: a prospective observational study in pediatric patients with bone sarcomas. Cancer Nursing2013;37(4):292-8.">Abate 2013</a>; <a href="./references#CD010996-bbs2-0045" title="KellyL . The care of vascular access devices in community care. British Journal of Community Nursing2008;13(5):198-205.">Kelly 2008</a>), or found no difference between groups (<a href="./references#CD010996-bbs2-0007" title="BritoARO , NishinariK , SaadPF , SaadKR , PereiraMAT , EmidioSCD , et al. Comparison between saline solution containing heparin versus saline solution in the lock of totally implantable catheters. Annals of Vascular Surgery2018;47:85-9. ">Brito 2018</a>); and institutions report the practice of using normal saline in their clinical practice guidelines (<a href="./references#CD010996-bbs2-0052" title="NelsonS , ArmesS , AustinA , ClarkN , HicksG , JohnstonJ , et al. Care and maintenance to reduce vascular access complications. Registered Nurse's Association of Ontario International Affairs and Best Practice Guidelines Programs Guidelines Supplement2008:1-7.">Nelson 2008</a>). </p> <p>Despite the literature suggesting that heparin may not be required to maintain patency of CVCs, more RCTs are required to determine the ideal flush solution, concentration, and the frequency of flushes (<a href="./references#CD010996-bbs2-0027" title="BaskinJL , Pui C-H, ReissU , WilimasJA , MetzgerML , RibeiroRC , et al. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet2009;374(9684):159-69.">Baskin 2009</a>). Without strong evidence to support the use of either solution, debate will continue and inconsistencies in practice will prevail. In an area where patients are already vulnerable as a result of their disease state, there should be greater understanding of this relatively simple question and practice should be standardised. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010996-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/urn:x-wiley:14651858:media:CD010996:CD010996-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010996-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_n/nCD010996-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_t/tCD010996-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/full#CD010996-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_n/nCD010996-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010996-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/urn:x-wiley:14651858:media:CD010996:CD010996-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010996-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_n/nCD010996-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_t/tCD010996-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/full#CD010996-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_n/nCD010996-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010996-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/urn:x-wiley:14651858:media:CD010996:CD010996-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010996-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_n/nCD010996-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_t/tCD010996-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/full#CD010996-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_n/nCD010996-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010996-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/urn:x-wiley:14651858:media:CD010996:CD010996-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Normal saline versus heparin flushing, Outcome 1: CVC occlusion rate per 1000 catheter days" data-id="CD010996-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_n/nCD010996-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_t/tCD010996-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Normal saline versus heparin flushing, Outcome 1: CVC occlusion rate per 1000 catheter days </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/references#CD010996-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_n/nCD010996-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010996-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/urn:x-wiley:14651858:media:CD010996:CD010996-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Normal saline versus heparin flushing, Outcome 2: CVC‐associated blood stream infection rate per 1000 catheter days" data-id="CD010996-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_n/nCD010996-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_t/tCD010996-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Normal saline versus heparin flushing, Outcome 2: CVC‐associated blood stream infection rate per 1000 catheter days </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/references#CD010996-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/media/CDSR/CD010996/image_n/nCD010996-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010996-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Does normal saline flushing in long‐term central venous catheters (CVC) prevent occlusion compared to heparin flushing in infants and children?</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Normal saline versus heparin flushing for prevention of occlusion in long‐term CVC in infants and children</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> infants and children with a long‐term CVC<br/><b>Settings:</b> tertiary hospitals<br/><b>Intervention:</b> normal saline flush<br/><b>Control:</b> heparin flush </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects * (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(RCTs)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p>Risk with <b>heparin flush</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p>Risk with <b>normal saline flush</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>CVC occlusion rate per 1000 catheter days:</b> ability to infuse solution through CVC </p> <p>Follow‐up: 3029 to 115,991 at‐risk days</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Rate ratio 0.75</b> <br/>(0.10 to 5.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>229<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>551 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>507 per 1000</b><br/>(99 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>CVC‐associated blood stream infection rate per 1000 catheter days:</b> incidence of positive blood culture </p> <p>Follow‐up: 3029 to 115,991 at‐risk days</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Rate ratio 1.48</b> <br/>(0.24 to 9.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>231<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>93 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>209 per 1000</b><br/>(103 to 425) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Duration of CVC placement (days)</b> </p> <p>Follow up: median 360 days</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>203</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b><sup>1,4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> reported this in terms of survival, not in days. Mean survival was reported as 77% (95% CI 66% to 84%) in the normal saline group and 69% (95% CI 53% to 80%) in the heparin group. No differences were found in cause or frequency of premature removal of catheter between study arms. The remaining studies did not report on this outcome. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>CVC</b> : Central venous catheter; <b>RCTs</b>: Randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>No blinding in either study. Performance and detection bias is high in both studies<br/><sup>2</sup>Heterogeneity and inconsistency between studies is high<br/><sup>3</sup>Confidence intervals were wide and included the null hypothesis<br/><sup>4</sup>Results could be attributed to other factors associated with the use of heparin<br/><sup>5</sup>The outcomes could also be attributed to the use of positive pressure cap in the <a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. ">Cesaro 2009</a> study  </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Does normal saline flushing in long‐term central venous catheters (CVC) prevent occlusion compared to heparin flushing in infants and children?</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/full#CD010996-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010996-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Rate per 1000 catheter days for primary and secondary outcomes</span></div> <tbody> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><a href="./references#CD010996-bbs2-0004" title="SmithS , DawsonS , HennesseyR , AndrewM . Maintenance of the patency of indwelling central venous catheters: is heparin necessary?American Journal of Pediatric Hematology/oncology1991;13(2):141-3. "><b>Smith 1991</b> </a> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><a href="./references#CD010996-bbs2-0001" title="CesaroS , TridelloG , CavaliereM , MagagnaL , GavinP , CusinatoR , et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology2009;27(12):2059-65. "><b>Cesaro 2009</b> </a> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><a href="./references#CD010996-bbs2-0003" title="GoosensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology2013;24(7):1892-9. GoossensGA , JeromeM , JanssensC , PeetermansWE , FieuwsS , MoonsP , et al. Heparin versus normal saline as locking solution in totally implantable venous ports: A randomized controlled trial in cancer patients. Supportive Care in Cancer2013;21:S28. "><b>Goossens 2013</b> </a> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Outcome</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Normal saline</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heparin</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Normal saline</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heparin</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Normal saline</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heparin</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CVC occlusion rate per 1000 catheter days</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.32</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.66</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.16</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.11</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.62</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.35</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CVC‐associated blood stream infection rate per 1000 catheter days</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.32</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.66</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.62</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.24</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.32</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.04</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inability to withdraw blood</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.42</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CVC dislodgement</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.65</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.47</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.54</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CVC site infection</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.31</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.26</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.38</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CVC‐related thrombosis</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.66</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.66</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.30</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.30</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>CVC: Central venous catheter</p> <p><a href="./references#CD010996-bbs2-0002" title="da SilvaRS . Effect of heparin to prevent obstruction of the Hickman catheter [Efetividade da solucao de heparina na prevencao de oclusao do cateter de kickman: ensaio clinico randomizado]. [Thesis dissertation] acervodigital.ufpr.br/handle/1884/56046 2018 (accessed 13 September 2019). ">da Silva 2018</a> not included in table as rate per 1000 catheter days not able to be calculated </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Rate per 1000 catheter days for primary and secondary outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/full#CD010996-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010996-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Normal saline versus heparin flushing</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 CVC occlusion rate per 1000 catheter days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>229</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.10, 5.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 CVC‐associated blood stream infection rate per 1000 catheter days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.48 [0.24, 9.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Normal saline versus heparin flushing</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010996.pub3/references#CD010996-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010996.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010996-note-0010">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010996-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010996-note-0008">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD010996-note-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010996-note-0005">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD010996-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010996\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010996\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010996\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010996\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010996\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010996\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010996\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010996\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010996\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010996\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010996\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010996\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010996\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010996\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010996\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010996\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010996\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010996\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jiwTpTuf&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010996.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010996.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010996.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010996.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010996.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725358766"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010996.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725358770"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010996.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e794ebe55936e',t:'MTc0MDcyNTM1OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 